Chris Ozer
November 10, 2022 6:04 AM EST

“You and I don’t get to choose the cancer we get,” says Dr. Joshua Ofman of Grail, Inc. But with this breakthrough lab test, doctors can choose to screen for over 50 types of cancers—about 10 times as many as can be screened for with current recommended tests. Galleri’s machine learning technology looks for circulating tumor DNA from a blood draw and claims a low false positive rate and high positive predictive value—in other words, it’s accurate. In the recent Pathfinder study, about 50% of the detected cancers were early stage. “Localized cancers in Stage 1 and 2 are often curable,” Ofman notes.

Request Now: Grail Galleri Cancer Test

More Must-Reads From TIME

Contact us at letters@time.com.

Augmented Job Training
Next-Level EV
Flash-Frozen Coffee to Go
Athletic Apparel for the Smartwatch Era
Meditate in the Metaverse
EDIT POST